Bone marrow-derived exosomes promote inflammation and osteoclast differentiation in high-turnover renal osteodystrophy

References

• Naylor KL, McArthur E, Leslie WD, et al. The three-year incidence of fracture in chronic kidney disease. Kidney Int. 2014;86(4):1–11. doi: 10.1038/ki.2013.547.
   Web of Science ®Google Scholar
• Coco M, Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis. 2000;36(6):1115–1121. doi: 10.1053/ajkd.2000.19812.
   PubMed Web of Science ®Google Scholar
• Moe SM. Renal osteodystrophy or kidney-induced osteoporosis? Curr Osteoporos Rep. 2017;15(3):194–197. doi: 10.1007/s11914-017-0364-1.
   PubMed Web of Science ®Google Scholar
• Moe S, Drüeke T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2006;69(11):1945–1953. doi: 10.1038/sj.ki.5000414.
   PubMed Web of Science ®Google Scholar
• Hoyland JA, Picton ML. Cellular mechanisms of renal osteodystrophy. Kidney Int Suppl. 1999;73: s 8–13. doi: 10.1046/j.1523-1755.1999.07312.x.
   Google Scholar
• Viaene L, Behets GJ, Heye S, et al. Inflammation and the bone-vascular axis in end-stage renal disease. Osteoporos Int. 2016;27(2):489–497. doi: 10.1007/s00198-015-3233-8.
   PubMed Web of Science ®Google Scholar
• Navarro-González JF, Mora-Fernández C, Muros M, et al. Mineral metabolism and inflammation in chronic kidney disease patients: a cross-sectional study. Clin J Am Soc Nephrol. 2009;4(10):1646–1654. doi: 10.2215/CJN.02420409.
   PubMed Web of Science ®Google Scholar
• Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9(8):581–593. doi: 10.1038/nri2567.
   PubMed Web of Science ®Google Scholar
• Camussi G, Deregibus MC, Bruno S, et al. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int. 2010;78(9):838–848. doi: 10.1038/ki.2010.278.
   PubMed Web of Science ®Google Scholar
• Marton N, Kovács OT, Baricza E, et al. Extracellular vesicles regulate the human osteoclastogenesis: divergent roles in discrete inflammatory arthropathies. Cell Mol Life Sci. 2017;74(19):3599–3611. doi: 10.1007/s00018-017-2535-8.
   PubMed Web of Science ®Google Scholar
• Kolhe R, Hunter M, Liu S, et al. Gender-specific differential expression of exosomal miRNA in synovial fluid of patients with osteoarthritis. Sci Rep. 2017;7(1):2029. doi: 10.1038/s41598-017-01905-y.
   PubMed Web of Science ®Google Scholar
• Meng Y, Zhang H, Li Y, et al. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats. Bone. 2014;58:168–176. doi: 10.1016/j.bone.2013.10.010.
   PubMed Web of Science ®Google Scholar
• Dempster DW, Compston JE, Drezner MK, et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR histomorphometry nomenclature committee. J Bone Miner Res. 2013;28(1):2–17. doi: 10.1002/jbmr.1805.
   PubMed Web of Science ®Google Scholar
• Redlich K, Smolen JS. Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat Rev Drug Discov. 2012;11(3):234–250. doi: 10.1038/nrd3669.
   PubMed Web of Science ®Google Scholar
• Fujiwara N, Kobayashi K. Macrophages in inflammation. Curr Drug Targets Inflamm Allergy. 2005;4(3):281–286. doi: 10.2174/1568010054022024.
   PubMedGoogle Scholar
• Chan BD, Wong WY, Lee MML, et al. Exosomes in inflammation and inflammatory disease. Proteomics. 2019;19(8):e1800149. doi: 10.1002/pmic.201800149.
   PubMed Web of Science ®Google Scholar
• Xie Y, Chen Y, Zhang L, et al. The roles of bone-derived exosomes and exosomal microRNAs in regulating bone remodelling. J Cell Mol Med. 2017;21(5):1033–1041. doi: 10.1111/jcmm.13039.
   PubMed Web of Science ®Google Scholar
• Withrow J, Murphy C, Liu Y, et al. Extracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritis. Arthritis Res Ther. 2016;18(1):286. doi: 10.1186/s13075-016-1178-8.
   PubMed Web of Science ®Google Scholar
• Damasiewicz MJ, Nickolas TL. Rethinking bone disease in kidney disease. JBMR plus. 2018;2(6):309–322. doi: 10.1002/jbm4.10117.
   PubMedGoogle Scholar
• Malluche HH, Ritz E, Lange HP, et al. Bone histology in incipient and advanced renal failure. Kidney Int. 1976;9(4):355–362. doi: 10.1038/ki.1976.42.
   PubMed Web of Science ®Google Scholar
• Coen G, Ballanti P, Bonucci E, et al. Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH. Nephron. 2002;91(1):103–111. doi: 10.1159/000057611.
   PubMed Web of Science ®Google Scholar
• Nickolas TL, Stein EM, Dworakowski E, et al. Rapid cortical bone loss in patients with chronic kidney disease. J Bone Miner Res. 2013;28(8):1811–1820. doi: 10.1002/jbmr.1916.
   PubMed Web of Science ®Google Scholar
• Mazzaferro S, Bagordo D, De Martini N, et al. Inflammation, oxidative stress, and bone in chronic kidney disease in the osteoimmunology era. Calcif Tissue Int. 2021;108(4):452–460. doi: 10.1007/s00223-020-00794-0.
   PubMed Web of Science ®Google Scholar
• Lin TH, Tamaki Y, Pajarinen J, et al. Chronic inflammation in biomaterial-induced periprosthetic osteolysis: NF-κB as a therapeutic target. Acta Biomater. 2014;10(1):1–10. doi: 10.1016/j.actbio.2013.09.034.
   PubMed Web of Science ®Google Scholar
• Neale Weitzmann M, Pacifici R. Parathyroid diseases and T cells. Curr Osteoporos Rep. 2017;15(3):135–141. doi: 10.1007/s11914-017-0359-y.
   PubMed Web of Science ®Google Scholar
• Gupta J, Mitra N, Kanetsky PA, et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol. 2012;7(12):1938–1946. doi: 10.2215/CJN.03500412.
   PubMed Web of Science ®Google Scholar
• Bergström J, Lindholm B, Lacson E, et al. What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients? Semin Dial. 2000;13(3):163–175. doi: 10.1046/j.1525-139x.2000.00044.x.
   PubMedGoogle Scholar
• Stenvinkel P. Inflammatory and atherosclerotic interactions in the depleted uremic patient. Blood Purif. 2001;19(1):53–61. doi: 10.1159/000014479.
   PubMed Web of Science ®Google Scholar
• Lv W, Booz GW, Wang Y, et al. Inflammation and renal fibrosis: recent developments on key signaling molecules as potential therapeutic targets. Eur J Pharmacol. 2018;820:65–76. doi: 10.1016/j.ejphar.2017.12.016.
   PubMed Web of Science ®Google Scholar
• Pino AM, Ríos S, Astudillo P, et al. Concentration of adipogenic and proinflammatory cytokines in the bone marrow supernatant fluid of osteoporotic women. J Bone Miner Res. 2010;25(3):492–498. doi: 10.1359/jbmr.090802.
   PubMed Web of Science ®Google Scholar
• Liu M, Sun Y, Zhang Q. Emerging role of extracellular vesicles in bone remodeling. J Dent Res. 2018;97(8):859–868. doi: 10.1177/0022034518764411.
   PubMed Web of Science ®Google Scholar
• Essandoh K, Yang L, Wang X, et al. Blockade of exosome generation with GW4869 dampens the sepsis-induced inflammation and cardiac dysfunction. Biochim Biophys Acta. 2015;1852(11):2362–2371. doi: 10.1016/j.bbadis.2015.08.010.
   PubMed Web of Science ®Google Scholar
• Bretz NP, Ridinger J, Rupp AK, et al. Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via toll-like receptor signaling. J Biol Chem. 2013;288(51):36691–36702. doi: 10.1074/jbc.M113.512806.
   PubMed Web of Science ®Google Scholar
• Singleton Q, Vaibhav K, Braun M, et al. Bone marrow derived extracellular vesicles activate osteoclast differentiation in traumatic brain injury induced bone loss. Cells. 2019;8(1):63. doi: 10.3390/cells8010063.
   PubMed Web of Science ®Google Scholar
• Song J, Kim D, Han J, et al. PBMC and exosome-derived hotair is a critical regulator and potent marker for rheumatoid arthritis. Clin Exp Med. 2015;15(1):121–126. doi: 10.1007/s10238-013-0271-4.
   PubMed Web of Science ®Google Scholar
• Davis C, Dukes A, Drewry M, et al. MicroRNA-183-5p increases with age in bone-derived extracellular vesicles, suppresses bone marrow stromal (stem) cell proliferation, and induces stem cell senescence. Tissue Eng Part A. 2017;23(21–22):1231–1240. doi: 10.1089/ten.tea.2016.0525.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhao W, Bao D, et al. miR-9-5p promotes wear-particle-induced osteoclastogenesis through activation of the SIRT1/NF-κB pathway. 3 Biotech. 2021;11(6):258. doi: 10.1007/s13205-021-02814-8.
   PubMedGoogle Scholar
• Najm A, Masson FM, Preuss P, et al. MicroRNA-17-5p reduces inflammation and bone erosions in mice with Collagen-Induced arthritis and directly targets the JAK/STAT pathway in rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheumatol. 2020;72(12):2030–2039. doi: 10.1002/art.41441.
   PubMed Web of Science ®Google Scholar
• Jin Y, Yao G, Wang Y, et al. MiR-30c-5p mediates inflammatory responses and promotes microglia survival by targeting eIF2α during Cryptococcus neoformans infection. Microb Pathog. 2020;141:103959. doi: 10.1016/j.micpath.2019.103959.
   PubMed Web of Science ®Google Scholar